Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Lipid Modification on Peripheral Arterial Disease After Endovascular Intervention ("The ELIMIT Trial")

NCT00687076 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT00687076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00687076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Lipid Modification on Peripheral Arterial Disease After Endovascular Intervention ("The ELIMIT Trial")
Lead sponsor
Baylor College of Medicine
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2004
Completion date
December 31, 2010
Enrollment
102 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease